These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21129948)

  • 1. High-dose oxytocin is not associated with maternal temperature elevation: a retrospective cohort study of mid-trimester pregnancy with intrauterine fetal demise.
    Frölich MA; Esame A; Warren Iii WM; Owen J
    Int J Obstet Anesth; 2011 Jan; 20(1):30-3. PubMed ID: 21129948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative routes of oxytocin administration in crated farrowing sows and its effects on fetal and postnatal asphyxia.
    Mota-Rojas D; Trujillo ME; Martínez J; Rosales AM; Orozco H; Ramírez R; Sumano H; Alonso-Spilsbury M
    Anim Reprod Sci; 2006 Mar; 92(1-2):123-43. PubMed ID: 16023309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal pulmonary oedema following oxytocin administration in a pregnant woman with acute myocardial infarction.
    Dogdu O; Yarlioglues M; Inanc T; Ardic I; Zencir C; Kaya MG
    Cardiovasc Toxicol; 2011 Mar; 11(1):74-7. PubMed ID: 21076981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of labor with misoprostol in pregnancies with advanced maternal age.
    Zeteroglu S; Sahin GH; Sahin HA
    Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):140-4. PubMed ID: 16406221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin for induction of labor.
    Smith JG; Merrill DC
    Clin Obstet Gynecol; 2006 Sep; 49(3):594-608. PubMed ID: 16885666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapartum synthetic oxytocin and breastfeeding: a retrospective cohort study.
    Gomes M; Trocado V; Carlos-Alves M; Arteiro D; Pinheiro P
    J Obstet Gynaecol; 2018 Aug; 38(6):745-749. PubMed ID: 29523035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a maximum dose of oxytocin affect risk for uterine rupture in candidates for vaginal birth after cesarean delivery?
    Cahill AG; Stamilio DM; Odibo AO; Peipert JF; Stevens EJ; Macones GA
    Am J Obstet Gynecol; 2007 Nov; 197(5):495.e1-5. PubMed ID: 17714683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn feeding behaviour depressed by intrapartum oxytocin: a pilot study.
    Olza Fernández I; Marín Gabriel M; Malalana Martínez A; Fernández-Cañadas Morillo A; López Sánchez F; Costarelli V
    Acta Paediatr; 2012 Jul; 101(7):749-54. PubMed ID: 22452314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of uterine activity. Using oxytocin after intracervical PGE2.
    Coleman FH; Rayburn WF; Burks LS; Farmer KC; Larson JD; Turnbull GL
    J Reprod Med; 1997 Jan; 42(1):44-8. PubMed ID: 9018645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
    King KJ; Douglas MJ; Unger W; Wong A; King RA
    Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of labor by oral administration of desamino-oxytocin].
    Rustichelli S; Jura R; Priolo A; Leidi L
    Riv Ital Ginecol; 1977; 58(5):357-69. PubMed ID: 555036
    [No Abstract]   [Full Text] [Related]  

  • 14. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
    Clark S; Belfort M; Saade G; Hankins G; Miller D; Frye D; Meyers J
    Am J Obstet Gynecol; 2007 Nov; 197(5):480.e1-5. PubMed ID: 17980181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nasal oxytocin on pregnancy rates following intrauterine insemination: double-blind, randomized, clinical pilot study.
    Ochsenkühn R; Pavlik R; Hecht S; von Schönfeldt V; Rogenhofer N; Thaler CJ
    Arch Gynecol Obstet; 2010 Apr; 281(4):753-9. PubMed ID: 19921230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The persistent problem of postpartum hemorrhage.
    Lowe NK
    J Obstet Gynecol Neonatal Nurs; 2012; 41(4):459-60. PubMed ID: 22804957
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxytocin as a high-alert medication: implications for perinatal patient safety.
    Simpson KR; Knox GE
    MCN Am J Matern Child Nurs; 2009; 34(1):8-15; quiz 16-7. PubMed ID: 19104313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dangers of rapid oxytocin administration in Eisenmenger's Syndrome.
    Yang CY; Wei W; Tao GC
    Int J Obstet Anesth; 2011 Jan; 20(1):96-7. PubMed ID: 21036595
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxytocin in parturients with cardiac disease.
    Tamhane P; O'Sullivan G; Reynolds F
    Int J Obstet Anesth; 2006 Oct; 15(4):332-3; author reply 333. PubMed ID: 16774825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.